RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus

House spending bill would give FDA drug recall authority

10 July 2020 | By Kari Oakes

The US House Committee on Appropriations approved a $3.212 billion budget for the Food and Drug Administration (FDA) on a voice vote...

Regulatory Exchange